Journal of Virology · 2018 · 55 citations · 50 references
Life SciencesBiologyMolecular BiologyGenomicsMolecular VirologyVirologyAntiviral TherapyViral GeneticsViral InfectionsViral MutationViral ReplicationVirus Genome OrganizationAntiviral TherapeuticsInfluenza Antiviral TherapyRna Virus BiologyViral Defective Interfering ParticlesViral Genome PackagingViral Genome StructureViral Rna Defective Interfering ParticlesViral Rna Packaging
Defective interfering particles (DIPs) typically contain a highly deleted form of the viral genome, rendering them defective in virus replication. Yet upon complementation through coinfection with fully infectious standard virus (STV), interference with the viral life cycle can be observed, leading to suppressed STV replication and the release of mainly noninfectious DIPs. Interestingly, recent research indicates that DIPs may serve as an antiviral agent. Here we report the discovery of a yet-unknown type of influenza A virus-derived DIP (termed "OP7" virus) that contains numerous point mutations instead of large deletions in its genome. Furthermore, the underlying principles that render OP7 virions interfering and apparently defective seem to differ from those of conventional DIPs. In conclusion, we believe that OP7 virus might be a promising candidate for antiviral therapy. Moreover, it exerts strong effects, both on virus replication and on the host cell response, and may have been overlooked in other IAV preparations.
50
Universal primer set for the full-length amplification of all influenza A viruses
E. Hoffmann, Jürgen Stech, Yi Guan et al. · Archives of Virology · 2001 · 2.1K citations · Full text
Defective Viral Particles and Viral Disease Processes
Alice Huang, David Baltimore · Nature · 1970 · 717 citations